Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
crispr
editas medicine
gene editing
katrine bosley
life sciences
national blog main
advaxis
aimmune therapeutics
alder biopharmaceuticals
alexander hardy
allergan
andrew oxtoby
babies
boston
boulder/denver blog main
boulder/denver top stories
breakup
bridge bio pharma
ceo
clinical hold
clinical study
clinical trials
combination
commissioner
congress
crispr-cas9
cynthia collins
delisting
democrats
departure
detroit blog main
detroit top stories
drug pricing
drugs
eli lilly
ethics
failure
What
ceo
2
×
crispr
editas
katrine
2
×
medicine
allergan
big
bio
blessing
bosley
bosley's
bosley’s
bridge
bucks
cas
check
clinical
crime
cusp
depart
departure
editing
exit
experimental
gene
guiding
humans
million
moves
partner
personnel
regulatory
roundup
surprising
test
therapy
trial
week
Language
Current search:
katrine
×
ceo
×
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
